Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 1, 2010, Pages 71.e1-71.e6

  Idahl, Annika ^a   Lundin, Eva ^a   Elgh, Fredrik ^a,b   Jurstrand, Margaretha ^c   Møller, Jens K ^e   Marklund, Ingrid ^a   Lindgren, Peter ^d   Ottander, Ulrika ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

bacteria; borderline ovarian tumors; infection; ovarian cancer; virus

Indexed keywords

ADULT; ARTICLE; BACTERIUM DETECTION; CANCER TISSUE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FEMALE; FROZEN SECTION; GYNECOLOGIC DISEASE; HUMAN; HUMAN TISSUE; JC VIRUS; MAJOR CLINICAL STUDY; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; NONHUMAN; OVARY CARCINOMA; OVARY TUMOR; POLYOMA VIRUS; PRIORITY JOURNAL; TISSUE PRESERVATION; VIRUS DETECTION; WART VIRUS;

EID: 72149121818     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.07.042     Document Type: Article

References (54)

1. Sankaranarayanan R., and Ferlay J. Worldwide burden of gynecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 20 (2006) 207-225
2. Moss S.F., and Blaser M.J. Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol 2 (2005) 90-97
3. Risch H.A., and Howe G.R. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 4 (1995) 447-451
4. Weström L., and Wølner-Hanssen P. Pathogenesis of pelvic inflammatory disease. Genitourin Med 69 (1993) 9-17
5. World Health Organization Task Force on the Prevention and Management of Infertility. Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. Sex Transm Dis 22 (1995) 71-77
6. Barrett S., and Taylor C. A review on pelvic inflammatory disease. Int J STD AIDS 16 (2005) 715-720
7. Ness R.B., Goodman M.T., Shen C., and Brunham R.C. Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer. J Infect Dis 187 (2003) 1147-1152
8. Ness R.B., Shen C., Bass D., et al. Chlamydia trachomatis serology in women with and without ovarian cancer. Infect Dis Obstet Gynecol 2008 (2008) 219672. Epub 2008 Dec 18
9. Wong A., Maclean A.B., Furrows S.J., Ridgway G.L., Hardiman P.J., and Perrett C.W. Could epithelial ovarian cancer be associated with chlamydial infection?. Eur J Gynaecol Oncol 28 (2007) 117-120
10. Toth M., Patton D.L., Campbell L.A., et al. Detection of chlamydial antigenic material in ovarian, prostatic, ectopic pregnancy and semen samples of culture-negative subjects. Am J Reprod Immunol 43 (2000) 218-222
11. Barlow R.E., Cooke I.D., Odukoya O., et al. The prevalence of Chlamydia trachomatis in fresh tissue specimens from patients with ectopic pregnancy or tubal factor infertility as determined by PCR and in-situ hybridization. J Med Microbiol 50 (2001) 902-908
12. Haggerty C.L. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr Opin Infect Dis 21 (2008) 65-69
13. Grzesko J., Elias M., Maczynska B., Kasprzykowska U., Tlaczala M., and Goluda M. Occurrence of Mycoplasma genitalium in fertile and infertile women. Fertil Steril 91 (2009) 2376-2380
14. Chan P.J., Seraj I.M., Kalugdan T.H., and King A. Prevalence of mycoplasma conserved DNA in malignant ovarian cancer detected using sensitive PCR-ELISA. Gynecol Oncol 63 (1996) 258-260
15. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates (2001), World Health Organization, Geneva
16. Taylor M.L., Mainous III A.G., and Wells B.J. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med 37 (2005) 506-512
17. Dennis L.K., and Dawson D.V. Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 13 (2002) 72-79
18. zur Hausen H. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 384 (2009) 260-265
19. Lai C.H., Hsueh S., Lin C.Y., et al. Human papillomavirus in benign and malignant ovarian and endometrial tissues. Int J Gynecol Pathol 11 (1992) 210-215
20. Kaufman R.H., Bornstein J., Gordon A.N., Adam E., Kaplan A.L., and Adler-Storthz K. Detection of human papillomavirus DNA in advanced epithelial ovarian carcinoma. Gynecol Oncol 27 (1987) 340-349
21. Li T., Lu Z.M., Guo M., et al. P53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 95 (2002) 2571-2576
22. Atalay F., Taskiran C., Taner M.Z., Pak I., Or M., and Tuncer S. Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma. J Obstet Gynaecol Res 33 (2007) 823-828
23. Wu Q.J., Guo M., Lu Z.M., Li T., Qiao H.Z., and Ke Y. Detection of human papillomavirus-16 in ovarian malignancy. Br J Cancer 89 (2003) 672-675
24. Ip S.M., Wong L.C., Xu C.M., Cheung A.N., Tsang P.C., and Ngan H.Y. Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of the upper genital tract. Gynecol Oncol 87 (2002) 104-111
25. Zimna K., Poreba E., Kedzia W., Gozdzicka-Jozefiak A., and Kedzia H. Human papillomavirus (HPV) in upper genital tract carcinomas of women. Eur J Gynaecol Oncol 18 (1997) 415-417
26. Kuscu E., Ozdemir B.H., Erkanli S., and Haberal A. HPV and p53 expression in epithelial ovarian carcinoma. Eur J Gynaecol Oncol 26 (2005) 642-645
27. Kedzia W.M., Gozdzicka-Jozefiak A., and Kedzia H. Human papillomavirus type 16 in ovarian serous surface papilloma. Eur J Gynaecol Oncol 17 (1996) 354-356
28. Lai C.H., Wang C.Y., Lin C.Y., and Pao C.C. Detection of human papillomavirus RNA in ovarian and endometrial carcinomas by reverse transcription/polymerase chain reaction. Gynecol Obstet Invest 38 (1994) 276-280
29. Giordano G., D'Adda T., Gnetti L., Froio E., Merisio C., and Melpignano M. Role of human papillomavirus in the development of epithelial ovarian neoplasms in Italian women. J Obstet Gynaecol Res 34 (2008) 210-217
30. Anwar K., Nakakuki K., Imai H., Shiraishi T., and Inuzuka M. Infection of human papillomavirus (HPV) and p53 over-expression in human female genital tract carcinoma. J Pak Med Assoc 46 (1996) 220-224
31. Beckmann A.M., Sherman K.J., Saran L., and Weiss N.S. Genital-type human papillomavirus infection is not associated with surface epithelial ovarian carcinoma. Gynecol Oncol 43 (1991) 247-251
32. McLellan R., Buscema J., Guerrero E., Shah K.V., Woodruff J.D., and Currie J.L. Investigation of ovarian neoplasia of low malignant potential for human papillomavirus. Gynecol Oncol 38 (1990) 383-385
33. Leake J.F., Woodruff J.D., Searle C., Daniel R., Shah K.V., and Currie J.L. Human papillomavirus and epithelial ovarian neoplasia. Gynecol Oncol 34 (1989) 268-273
34. Trottier A.M., Provencher D., Mes-Masson A.M., Vauclair R., and Coutlee F. Absence of human papillomavirus sequences in ovarian pathologies. J Clin Microbiol 33 (1995) 1011-1013
35. Chen T.R., Chan P.J., Seraj I.M., and King A. Absence of human papillomavirus E6-E7 transforming genes from HPV 16 and 18 in malignant ovarian carcinoma. Gynecol Oncol 72 (1999) 180-182
36. Anttila M., Syrjanen S., Ji H., Saarikoski S., and Syrjanen K. Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol 72 (1999) 337-341
37. Quirk J.T., Kupinski J.M., and DiCioccio R.A. Analysis of ovarian tumors for the presence of human papillomavirus DNA. J Obstet Gynaecol Res 32 (2006) 202-205
38. Hisada M., van den Berg B.J., Strickler H.D., et al. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States). Cancer Causes Control 12 (2001) 335-341
39. Lee W., and Langhoff E. Polyomavirus in human cancer development. Adv Exp Med Biol 577 (2006) 310-318
40. Moens U., Van Ghelue M., and Johannessen M. Oncogenic potentials of the human polyomavirus regulatory proteins. Cell Mol Life Sci 64 (2007) 1656-1678
41. Tavassoli F.A., and Devilee P. World Health Organization classification of tumors: pathology and genetics of tumors of the breast and female genital organs (2003), IARC Press, Lyon
42. Møller J.K., Pedersen L.N., and Persson K. Comparison of Gen-probe transcription-mediated amplification, Abbott PCR, and Roche PCR assays for detection of wild-type and mutant plasmid strains of Chlamydia trachomatis in Sweden. J Clin Microbiol 46 (2008) 3892-3895
43. Jensen J.S., Bjornelius E., Dohn B., and Lidbrink P. Use of TaqMan 5' nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic. J Clin Microbiol 42 (2004) 683-692
44. Edberg A., Jurstrand M., Johansson E., et al. A comparative study of three different PCR assays for detection of Mycoplasma genitalium in urogenital specimens from men and women. J Med Microbiol 57 (2008) 304-309
45. Greer C.E., Wheeler C.M., and Manos M.M. Sample preparation and PCR amplification from paraffin-embedded tissues. PCR Methods Appl 3 (1994) S113-S122
46. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., and Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76 (1995) 1057-1062
47. Auersperg N., Woo M.M., and Gilks C.B. The origin of ovarian carcinomas: a developmental view. Gynecol Oncol 110 (2008) 452-454
48. Carvalho J.P., and Carvalho F.M. Is Chlamydia-infected tubal fimbria the origin of ovarian cancer?. Med Hypotheses 71 (2008) 690-693
49. Micke P., Ohshima M., Tahmasebpoor S., et al. Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens. Lab Invest 86 (2006) 202-211
50. Jochumsen K.M., Tan Q., Dahlgaard J., Kruse T.A., and Mogensen O. RNA quality and gene expression analysis of ovarian tumor tissue undergoing repeated thaw-freezing. Exp Mol Pathol 82 (2007) 95-102
51. Wallin K.L., Wiklund F., Luostarinen T., et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer 101 (2002) 371-374
52. Paavonen J., Karunakaran K.P., Noguchi Y., et al. Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer. Am J Obstet Gynecol 189 (2003) 1287-1292
53. Naucler P., Chen H.C., Persson K., et al. Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol 88 (2007) 814-822
54. Parsonnet J., Hansen S., Rodriguez L., et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330 (1994) 1267-1271